(Q36116515)

12 August 2017

1 reference

title

The value of FDG positron emission tomography in the management of patients with breast cancer (English)

1 reference

positron emission tomography

12 August 2017

main subject

1 reference

Lorna Weir

1

1 reference

12 August 2017

Daniel Worsley

series ordinal

2

1 reference

12 August 2017

Vanessa Bernstein

series ordinal

3

1 reference

12 August 2017

publication date

1 May 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

11

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

204-209

1 reference

Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21625.X

Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21625.X

Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21625.X

Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: not yet!

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21625.X

Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21625.X

Fluorine-18 FDG-PET in detecting local recurrence and distant metastases in breast cancer--Taiwanese experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21625.X

Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21625.X

Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21625.X

Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21625.X

10.1111/J.1075-122X.2005.21625.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference